This downloadable slideset reviews new, clinically relevant HIV data, with emphasis on PrEP outcomes, ART efficacy in first-line and switch settings, metabolic and weight considerations with HIV therapy, and regimen selection during pregnancy.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new HIV data presented at 3 recent conferences, including data on HIV prevention, first-line and switch strategies, and weight gain during ART.
Earlier this year, the US government released a plan, with PrEP among its foundational pillars, to substantially reduce new HIV infections. Here’s my take on how data from IDWeek 2019 appraise progress toward this goal.
EACS 2019 delivered a wealth of new data applicable to women with HIV. Why is this so important? Here’s my take.